Skip to Content
You are currently on the new version of our website. Access the old version .

816 Results Found

  • Review
  • Open Access
20 Citations
23,735 Views
13 Pages

Fixed-Dose Combination of NSAIDs and Spasmolytic Agents in the Treatment of Different Types of Pain—A Practical Review

  • Magdalena Janczura,
  • Małgorzata Kobus-Moryson,
  • Szymon Sip,
  • Marcin Żarowski and ,
  • Agnieszka Wareńczak and
  • Judyta Cielecka-Piontek
  • + 1 author+ 0 author

15 July 2021

This review presents the most common disease entities in which combinations of NSAIDs and spasmolytic drugs are used to reduce pain. The benefits of fixed-dose combination products (FDCs) are that they improve the response in people with insufficient...

(This article belongs to the Special Issue Pharmacological Management of Chronic Pain)
  • Review
  • Open Access
658 Views
14 Pages

Fixed Dose Combinations as an Advantage for the Treatment of Pediatric Tuberculosis: A Narrative Review

  • Susanna Esposito,
  • Beatrice Rita Campana,
  • Gaia Giorgia Arnesano and
  • Nicola Principi

Background: Pediatric tuberculosis (TB) remains a major global health concern, accounting for a substantial proportion of TB-related morbidity and mortality worldwide. Treatment in children is particularly challenging due to age-specific pharmacokine...

(This article belongs to the Section Pharmaceutical Technology)
  • Article
  • Open Access
6 Citations
2,730 Views
21 Pages

Real-World Evidence of Regorafenib Dose Escalation Versus Fixed Dosing in Refractory Metastatic Colorectal Cancer: Results from the ReTrITA Study

  • Carlo Signorelli,
  • Michele Basso,
  • Maria Alessandra Calegari,
  • Annunziato Anghelone and ,
  • Alessandro Passardi,
  • Chiara Gallio,
  • Alessandro Bittoni,
  • Jessica Lucchetti,
  • Lorenzo Angotti and
  • Mario Giovanni Chilelli
  • + 26 authors+ 21 authors

14 October 2025

Background: Regorafenib is a recognised treatment for refractory metastatic colorectal cancer (mCRC). The phase II ReDOS trial indicated that a stepwise dose escalation approach could enhance tolerability and persistence while maintaining efficacy. T...

(This article belongs to the Section Cancer Metastasis)
  • Article
  • Open Access
15 Citations
9,606 Views
17 Pages

Budget Impact Analysis of Fixed Dose Versus Weight-Based Dosing Regimen of Nivolumab and Pembrolizumab in the Treatment of Non-Small Cell Lung Cancer

  • Sanjana Monirul,
  • Marthe Rigal,
  • Kader Chouahnia,
  • Mélisande Le Jouan and ,
  • Maxime Apparuit,
  • Adrien Paix,
  • Anne Jacolot,
  • Laurent Zelek and
  • Boris Duchemann
  • + 4 authors+ 0 author

3 December 2020

In 2018, dosing regimens of the two most prescribed immune check point inhibitors (ICI), nivolumab (Opdivo®) and pembrolizumab (Keytruda®), in the treatment of lung cancer were changed from weight-based dosing to fixed dosing. The aim of this...

(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)
  • Perspective
  • Open Access
1 Citations
2,594 Views
10 Pages

Facilitators and Barriers of Incremental Innovation by Fixed Dose Combinations in Cardiovascular Diseases

  • András Inotai,
  • Zoltán Kaló,
  • Zsuzsanna Petykó,
  • Kristóf Gyöngyösi and ,
  • Derek T. O’Keeffe,
  • Marcin Czech and
  • Tamás Ágh
  • + 2 authors+ 0 author

Despite the availability of affordable pharmaceuticals treating cardiovascular diseases (CVDs), many of the risk factors remain poorly controlled. Fixed-dose combinations (FDCs), a form of incremental innovation, have already demonstrated improvement...

(This article belongs to the Section Basic and Translational Cardiovascular Research)
  • Review
  • Open Access
72 Citations
16,808 Views
22 Pages

The development of innovative forms of combination drugs is closely related to the invention of the multilayer tablet press, polymers for pharmaceutical applications, the hot-melt extrusion process, and 3D printing in the pharmaceutical industry. How...

(This article belongs to the Section Drug Delivery and Controlled Release)
  • Review
  • Open Access
21 Citations
21,901 Views
31 Pages

31 July 2023

The combination of non-steroidal anti-inflammatory drugs (NSAIDs) with non-opioid analgesics is common in clinical practice for the treatment of acute painful conditions like post-operative and post-traumatic pain. Despite the satisfactory results ac...

(This article belongs to the Section Pharmaceutical Technology)
  • Article
  • Open Access
14 Citations
7,805 Views
9 Pages

Pharmacokinetics of a Fixed-Dose Combination Product of Dapagliflozin and Linagliptin and Its Comparison with Co-Administration of Individual Tablets in Healthy Humans

  • Jin-Woo Park,
  • Jong-Min Kim,
  • Ji Hyeon Noh,
  • Kyoung-Ah Kim and ,
  • Hyewon Chung,
  • EunJi Kim,
  • Minja Kang and
  • Ji-Young Park
  • + 3 authors+ 0 author

Dapagliflozin, a selective sodium–glucose co-transporter-2 inhibitor, and linagliptin, a competitive, reversible dipeptidyl peptidase-4 inhibitor, are commonly prescribed antidiabetic medications in general clinics. Since there are several meri...

(This article belongs to the Special Issue Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy)
  • Article
  • Open Access
17 Citations
4,563 Views
14 Pages

Preformulation Studies of Ezetimibe-Simvastatin Solid Dispersions in the Development of Fixed-Dose Combinations

  • Agata Górniak,
  • Adrianna Złocińska,
  • Mateusz Trojan,
  • Adrianna Pęcak and
  • Bożena Karolewicz

Two active pharmaceutical ingredients (APIs) with limited solubility, simvastatin and ezetimibe, prepared as a drug-drug solid dispersion (SD) was evaluated for physicochemical, microstructural, and aqueous dissolution properties. The simvastatin-eze...

(This article belongs to the Special Issue Advances in Pharmaceutical Solid Forms)
  • Article
  • Open Access
1,079 Views
18 Pages

A Multivariate Approach to the Simultaneous Spectrophotometric Determination of Perindopril Erbumine, Amlodipine Besylate and Indapamide in Fixed-Dose Combination

  • Jevrem Stojanović,
  • Huseinatu Osman,
  • Ana Protić,
  • Anđelija Malenović and ,
  • Mira Zečević,
  • Biljana Otašević and
  • Nataša Avramović
  • + 2 authors+ 0 author

Spectrophotometry offers the advantage of low cost and less time consumption, making it still attractive as a method of analysis, especially when coupled with multivariate calibration models. This enhancement solves the majority of the drawbacks of U...

(This article belongs to the Section Spectroscopy)
  • Article
  • Open Access
4 Citations
10,452 Views
18 Pages

The purpose of this study was to enhance the stability of montelukast and levocetirizine for the development of a fixed-dose combination (FDC) monolayer tablet. To evaluate the compatibility of montelukast and levocetirizine, a mixture of the two dru...

(This article belongs to the Special Issue Pharmaceutical Solid Forms: From Crystal Structure to Formulation)
  • Article
  • Open Access
1,604 Views
13 Pages

Critical Analysis of Fixed-Dose Antibiotic Combinations Sold in Kinshasa—Democratic Republic of the Congo

  • Jocelyn Kakumba Mankulu,
  • Dadit Kitenge Ive,
  • Freddy Mugisho Kasago,
  • Exaucé Mpuya Mpuya and ,
  • Bertin K. Mfuamba,
  • Jean-Pierre Mufusama Koy Sita,
  • Patient Ciza Hamuli,
  • Trésor Kimbeni Malongo,
  • Jérémie Mbinze Kindenge and
  • Didi Mana Kialengila
  • + 6 authors+ 1 author

Background: Fixed-dose combination drugs (FDCs) are combinations of two or more active ingredients in a single dosage form. These formulations have proven effective in combating the development of resistance in diseases such as tuberculosis and malar...

(This article belongs to the Special Issue Antimicrobial Stewardship—from Projects to Standard of Care)
  • Article
  • Open Access
2,374 Views
10 Pages

14 August 2020

Background: The aim of this study was to evaluate outcomes in patients with submacular hemorrhage secondary to polypoidal choroidal vasculopathy (PCV) after switching treatment from a fixed-dose to an as-needed regimen. Methods: This retrospective st...

(This article belongs to the Section Ophthalmology)
  • Article
  • Open Access
1 Citations
2,819 Views
10 Pages

Symptom-Triggered Alcohol Detoxification Compared to Fixed-Dose Regimen of Benzodiazepines: A Retrospective Case–Control Study

  • Laurent Becciolini,
  • Fabienne Wehrli,
  • Jens Kronschnabel,
  • Carolina Wiesendanger and ,
  • Norbert Scherbaum and
  • Patrik Roser
  • + 1 author+ 0 author

Background: Alcohol withdrawal syndrome is a common clinical challenge that may lead to significant complications if not properly managed. Symptom-triggered therapy (STT) represents a promising alternative to fixed-dose regimens (FDRs) providing benz...

(This article belongs to the Special Issue Psychiatry and Addiction: A Multi-Faceted Issue)
  • Review
  • Open Access
64 Citations
17,863 Views
36 Pages

Fixed-Dose Combination Formulations in Solid Oral Drug Therapy: Advantages, Limitations, and Design Features

  • Christi A. Wilkins,
  • Hannlie Hamman,
  • Josias H. Hamman and
  • Jan H. Steenekamp

Whilst monotherapy is traditionally the preferred treatment starting point for chronic conditions such as hypertension and diabetes, other diseases require the use of multiple drugs (polytherapy) from the onset of treatment (e.g., human immunodeficie...

(This article belongs to the Section Pharmaceutical Technology, Manufacturing and Devices)
  • Article
  • Open Access
2 Citations
3,221 Views
25 Pages

Development and Preclinical Evaluation of Fixed-Dose Capsules Containing Nicergoline, Piracetam, and Hawthorn Extract for Sensorineural Hearing Loss

  • Lucia Maria Rus,
  • Andrei Uncu,
  • Sergiu Parii,
  • Alina Uifălean and ,
  • Simona Codruța Hegheș,
  • Cristina Adela Iuga,
  • Ioan Tomuță,
  • Ecaterina Mazur,
  • Diana Șepeli and
  • Livia Uncu
  • + 8 authors+ 3 authors

Background: Fixed-dose combinations have advanced in many therapeutic areas, including otorhinolaryngology, where hearing disorders are increasingly prevalent. Objectives: The present study focuses on developing and evaluating a new capsule combining...

(This article belongs to the Section Physical Pharmacy and Formulation)
  • Article
  • Open Access
10 Citations
5,303 Views
15 Pages

Drug–Drug Compatibility Evaluation of Sulfasalazine and Folic Acid for Fixed-Dose Combination Development Using Various Analytical Tools

  • Mario-Livio Jeličić,
  • Edvin Brusač,
  • Stanislav Kurajica,
  • Matija Cvetnić and ,
  • Daniela Amidžić Klarić,
  • Biljana Nigović and
  • Ana Mornar
  • + 2 authors+ 0 author

The simultaneous administration of sulfasalazine and folic acid is regular practice in the therapy of inflammatory bowel diseases in order to maintain sufficient folate concentration in patients. Having multiple drugs in the therapy increases the pos...

(This article belongs to the Special Issue Drug Stability and Stabilization Techniques Volume II)
  • Article
  • Open Access
3 Citations
3,178 Views
30 Pages

Background/Objectives: Fixed-dose combination (FDC) antihypertensive medications containing olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide are widely used for the treatment of essential hypertension. Although effective, the use of...

(This article belongs to the Special Issue Advancements in Tablet Formulation and Technological Innovations in Pharmaceutical Manufacturing)
  • Article
  • Open Access
6 Citations
699 Views
15 Pages

Short- and Mid-Term Outcomes of Fixed-Dose Tramadol/Paracetamol in Early-Stage Symptomatic Knee Osteoarthritis: A Single-Center Retrospective Observational Extension Study

  • Valerio Cipolloni,
  • Marco Bonifacio,
  • Marco Giuseppe Musorrofiti,
  • Raoul Saggini and ,
  • Alessia Caldarola,
  • Gilberto Grossi,
  • Roberto Piazza,
  • Mario Mangrella,
  • Deborah Trastulli and
  • Alessandro Conforti
  • + 5 authors+ 0 author

8 June 2026

Background: A previous short-term retrospective analysis from our center suggested early improvement in pain, function, and sleep outcomes after fixed-dose tramadol/paracetamol therapy in patients with early-stage symptomatic knee osteoarthritis (KOA...

(This article belongs to the Special Issue Molecular Mechanisms and Pharmacological Innovations of Osteoarthritis)
  • Article
  • Open Access
8 Citations
4,026 Views
12 Pages

Trends of Fixed-Dose Combination Antibiotic Consumption in Hospitals in China: Analysis of Data from the Center for Antibacterial Surveillance, 2013–2019

  • Haishaerjiang Wushouer,
  • Lin Hu,
  • Yue Zhou,
  • Yaoyao Yang and ,
  • Kexin Du,
  • Yanping Deng,
  • Qing Yan,
  • Xiaoqiang Yang,
  • Zhidong Chen and
  • Luwen Shi
  • + 7 authors+ 2 authors

Background: Fixed-dose combination (FDC) antibiotics can be clinically inappropriate and are concerning with regards to antimicrobial resistance, with little usage data available in low- and middle-income countries. Methods: Based on retrospective da...

(This article belongs to the Section Antibiotics Use and Antimicrobial Stewardship)
  • Article
  • Open Access
476 Views
24 Pages

Bioequivalence Assessment of Sitagliptin/Metformin Extended-Release Fixed-Dose Combinations in Healthy Mexican Subjects Under Fasting and Fed Conditions

  • Omar Emmanuel Hernández Piña,
  • Porfirio de la Cruz Cruz,
  • Erika Gabriela Guido Ávila,
  • Alberto Martínez Muñoz and ,
  • José Trinidad Pérez Urizar and
  • Abraham Escobedo-Moratilla
  • + 1 author+ 0 author

27 September 2026

Background/Objectives: Management of Type 2 Diabetes (T2D) frequently requires combination therapy. Fixed-dose combinations (FDCs) of sitagliptin and extended-release (ER) metformin improve therapeutic adherence but pose biopharmaceutical challenges...

(This article belongs to the Section Pharmaceutical Technology)
  • Article
  • Open Access
1 Citations
2,154 Views
11 Pages

3 December 2025

(1) Background: Fixed-dose combination (FDC) improves patient convenience and therapeutic adherence by combining suitable drugs in a single dose form. This study examined the in vitro dissolution of an ibuprofen-loratadine FDC oral suspension to comm...

(This article belongs to the Collection Feature Papers in Solutions and Liquid Mixtures Research)
  • Article
  • Open Access
8 Citations
4,886 Views
22 Pages

Single-Agent and Fixed-Dose Combination HIV-1 Protease Inhibitor Drugs in Fission Yeast (Schizosaccharomyces pombe)

  • Jiantao Zhang,
  • Kasey Vernon,
  • Qi Li,
  • Zsigmond Benko and ,
  • Anthony Amoroso,
  • Mohamed Nasr and
  • Richard Y. Zhao
  • + 2 authors+ 0 author

Successful combination antiretroviral therapies (cART) eliminate active replicating HIV-1, slow down disease progression, and prolong lives. However, cART effectiveness could be compromised by the emergence of viral multidrug resistance, suggesting t...

(This article belongs to the Section Vaccines and Therapeutic Developments)
  • Article
  • Open Access
583 Views
19 Pages

A Fixed-dose combination (FDC) therapy of ezetimibe (EZT) and atorvastatin (ATV) is increasingly prescribed for high-risk hyperlipidemic patients with cardiovascular disease. However, the pharmaceutical production of FDC EZT/ATV tablets often results...

  • Article
  • Open Access
9 Citations
3,728 Views
17 Pages

Highly lipophilic antimalarial drugs, artemether and lumefantrine, whilst an effective fixed-dose combination treatment to lower the malarial disease burden, are therapeutically hindered by low aqueous solubility and varied bioavailability. This work...

(This article belongs to the Special Issue Solubilization and Controlled Release of Poorly Water-Soluble Drugs)
  • Article
  • Open Access
3 Citations
2,232 Views
13 Pages

28 March 2025

Changes in the dosing schedules for immune checkpoint inhibitors, specifically nivolumab and pembrolizumab, in the treatment of metastatic melanoma, were introduced based on pharmacokinetic data and analysis of pre-existing clinical trial data in the...

(This article belongs to the Special Issue Evidence from the Real World Provides New Insights into the Evolving Landscape of Cancer Immunotherapy)
  • Article
  • Open Access
2 Citations
3,418 Views
14 Pages

Background/Objectives: Effective airway delivery of a fixed-dose combination of triple-aerosolized inhaled corticosteroid (ICS)/long-acting beta agonist (LABA)/long-acting muscarinic antagonist (LAMA) is likely to positively affect therapeutic respon...

(This article belongs to the Special Issue Advances in the Preparation and Technology of Pharmaceutical Solid Dosage Forms)
  • Article
  • Open Access
15 Citations
5,972 Views
33 Pages

Control strategy and quality by design (QbD) are widely used to develop pharmaceutical products and improve drug quality; however, studies on fixed-dose combination (FDC) bilayer tablets are limited. In this study, the bilayer tablet consisted of hig...

  • Article
  • Open Access
4 Citations
3,041 Views
9 Pages

20 December 2022

This study assessed blood pressure (BP) control and adherence in patients given a fixed-dose combination (FDC) of bisoprolol (BIS) + aspirin (ASA) compared to those given these two drugs as separate tablets. Patients with hypertension and/or coronary...

(This article belongs to the Section Cardiovascular Medicine)
  • Article
  • Open Access
3 Citations
768 Views
9 Pages

Impact of Health Technology Assessment on Prescribing Patterns of Inhaled Fixed-Dose Combination Triple Therapy in Chronic Obstructive Pulmonary Disease

  • Jennifer Cook,
  • Chloe Bloom,
  • Jen Lewis,
  • Zoe Marjenberg and ,
  • Jaime Hernando Platz and
  • Sue Langham
  • + 1 author+ 0 author

Background: Evidence suggests that triple therapy for patients with chronic obstructive pulmonary disease (COPD) is being used in a broader range of patients than recommended by guidelines, which may have health and cost implications. Objective: To...

  • Article
  • Open Access
2 Citations
5,418 Views
18 Pages

8 November 2021

Background: Chronic Obstructive Pulmonary Disease (COPD) is an inflammatory lung disease characterized by airflow limitation that is not completely reversible. The fixed-dose combination of salmeterol and fluticasone propionate (SFC) has been approve...

(This article belongs to the Section Methodology, Drug and Device Discovery)
  • Article
  • Open Access
353 Views
19 Pages

A Phase III, Randomized, Double-Blind Clinical Trial of a Novel Triple Fixed-Dose Combination (Glimepiride/Vildagliptin/Metformin) in Mexican Adults with Uncontrolled Type 2 Diabetes After Dual Oral Therapy Failure

  • Ana Cristina García-Ulloa,
  • Victor Bohorquez-López,
  • Ana Flores-Barranco,
  • Salvador Pérez-Jaime and ,
  • Ivonne Bourget-Ontiveros,
  • Juan A. Becerra-Hernandez,
  • Kevin F. Rios-Brito,
  • Miguel A. Martinez-Hernandez,
  • Cuitlahuac Gasca-Chavez and
  • Jorge González-Canudas
  • + 8 authors+ 3 authors

Background/Objectives: Achieving glycaemic control remains challenging in patients with type 2 diabetes mellitus (T2DM). Fixed-dose combinations with complementary mechanisms may facilitate treatment intensification and improve adherence. This study...

(This article belongs to the Special Issue Early Intervention and Treatment Strategies for Diabetes)
  • Opinion
  • Open Access
3 Citations
6,595 Views
8 Pages

28 March 2023

(1) Background: There is a high burden of poor glycemic control in the Indian population with type 2 diabetes mellitus (T2DM). Currently, the use of metformin sustained-release (SR)–vildagliptin fixed-dose combination (FDC) is very low as compa...

  • Article
  • Open Access
4 Citations
2,206 Views
20 Pages

Background/Objectives: Fixed-dose combinations (FDCs) hold significant clinical value for the management of hypertension, diabetes and other chronic diseases. However, since the complexity of formulations, generic compounds require both in vitro phar...

(This article belongs to the Special Issue In Vitro–In Vivo Correlation and Mechanistic Pharmacokinetic Models: Bridging Drug In Vitro Characteristics and In Vivo Behaviors)
  • Article
  • Open Access
3,364 Views
10 Pages

27 November 2022

The efficacy of the fix-dose salmeterol/fluticasone propionate combination in chronic obstructive pulmonary disease (COPD) was only shown for the original product. This investigator-initiated study aimed to prove the efficacy and safety of Salflumix...

(This article belongs to the Special Issue Asthma and Respiratory Disease: Prediction, Diagnosis and Treatment)
  • Article
  • Open Access
1 Citations
2,716 Views
14 Pages

25 September 2025

Background: Fixed-dose combination medications (FDCs) are recognized methods of increasing adherence to polytherapy in chronic diseases. However, the role of FDCs in patients with benign prostatic hyperplasia (BPH) associated with lower urinary tract...

(This article belongs to the Special Issue Innovative Drug Strategies in Chronic Disease Management: Addressing Non-Adherence and Improving Therapeutic Outcomes)
  • Article
  • Open Access
1,132 Views
15 Pages

10 April 2026

Background/Objectives: Rho-associated protein kinase inhibitors reduce intraocular pressure (IOP) by enhancing aqueous humor outflow through the trabecular meshwork–Schlemm’s canal pathway. However, it remains unclear whether the fixed-do...

(This article belongs to the Section Ophthalmology)
  • Article
  • Open Access
6 Citations
3,211 Views
15 Pages

Screening of Fenofibrate-Simvastatin Solid Dispersions in the Development of Fixed-Dose Formulations for the Treatment of Lipid Disorders

  • Agata Górniak,
  • Hanna Czapor-Irzabek,
  • Adrianna Złocińska,
  • Agnieszka Gawin-Mikołajewicz and
  • Bożena Karolewicz

The combination of statins and fibrates in the treatment of lipid abnormalities effectively regulates individual lipid fraction levels. In this study, the screening and assessment of the physicochemical properties of simvastatin-fenofibrate solid dis...

(This article belongs to the Special Issue Recent Advances in Oral Solid Dosages)
  • Article
  • Open Access
1 Citations
1,871 Views
15 Pages

18 November 2025

Background/Objectives: Currently, treatments for age-related macular degeneration (AMD) consist of regular intravitreal injections that exert significant pressure on healthcare systems via their high labor costs and economic burden. To address this,...

(This article belongs to the Special Issue Advances in the Diagnosis and Management of Age-Related Macular Degeneration: 2nd Edition)
  • Study Protocol
  • Open Access
1 Citations
3,884 Views
9 Pages

23 April 2022

This retrospective review evaluated our institutions’ practice of administering low fixed-dose FEIBA (high (1000 units) or low dose (500 units) for an INR ≥ 5 or <5, respectively) for the management of warfarin-associated coagulopathies....

(This article belongs to the Section Pharmacy Practice and Practice-Based Research)
  • Article
  • Open Access
13 Citations
7,907 Views
10 Pages

8 November 2020

The optimal intrathecal dose of local anaesthetic for caesarean section (CS) anaesthesia is still being debated. We performed a study to compare the effectiveness and safety of spinal anaesthesia with 12.5 mg of hyperbaric bupivacaine and a dosing re...

(This article belongs to the Section Anesthesiology)
  • Article
  • Open Access
2 Citations
6,260 Views
9 Pages

17 January 2025

Background and Objectives: Neuromuscular blocking agents are essential to ensure optimal surgical conditions during general anesthesia. Sugammadex, a selective binding agent, is widely used to reverse neuromuscular blockade. While weight-based dosing...

(This article belongs to the Section Intensive Care/ Anesthesiology)
  • Review
  • Open Access
2 Citations
942 Views
7 Pages

10 March 2015

Combination therapy with anticholinergics and β2-agonists should be used in COPD patients after failure of previous monotherapy with one of these drugs. Synergistic effect of both mechanisms of bronchodilation can maximize the efficacy of separately...

  • Review
  • Open Access
9 Citations
5,644 Views
11 Pages

29 September 2022

Psoriasis is a lifelong disease which requires treatment adherence for successful management. Considering the complexity of this pathology, the combination of active pharmaceutical ingredients with a synergistic mechanism of action can improve the sa...

(This article belongs to the Special Issue Advances in Topical and Transdermal Drug Delivery)
  • Systematic Review
  • Open Access
2,263 Views
37 Pages

Background/Objectives: Postoperative pain remains a significant clinical challenge, often requiring multimodal strategies to mitigate opioid-related adverse events. The fixed-dose combination (FDC) of Diclofenac, a non-steroidal anti-inflammatory dru...

  • Article
  • Open Access
1 Citations
4,074 Views
7 Pages

The Australian Asthma Handbook does not recommend use of fixed dose combination (FDC) controller medicines for asthma in children aged ≤5 years. FDCs are only recommended in children and adolescents (aged 6–18 years) not responding to initia...

(This article belongs to the Special Issue Drug Utilisation Studies in Paediatrics)
  • Article
  • Open Access
5 Citations
3,084 Views
10 Pages

22 July 2022

Background. Fixed-dose ultrasound-assisted catheter-directed thrombolysis (USAT) rapidly improves hemodynamic parameters and reverses right ventricular dysfunction caused by acute pulmonary embolism (PE). The effectiveness of USAT for acute PE associ...

(This article belongs to the Special Issue COVID-19 and Cardiac Injury)
  • Article
  • Open Access
6 Citations
4,723 Views
15 Pages

Is Dosing of Ethambutol as Part of a Fixed-Dose Combination Product Optimal for Mechanically Ventilated ICU Patients with Tuberculosis? A Population Pharmacokinetic Study

  • Francisco Beraldi-Magalhaes,
  • Suzanne L. Parker,
  • Cristina Sanches,
  • Leandro Sousa Garcia and ,
  • Brenda Karoline Souza Carvalho,
  • Mariana Millan Fachi,
  • Marcus Vinicius de Liz,
  • Roberto Pontarolo,
  • Jeffrey Lipman and
  • Jason A. Roberts
  • + 6 authors+ 1 author

20 December 2021

Background: Tuberculosis (TB) patients admitted to intensive care units (ICU) have high mortality rates. It is uncertain whether the pharmacokinetics of first-line TB drugs in ICU patients are different from outpatients. This study aims to compare th...

(This article belongs to the Section Pharmacokinetics and Pharmacodynamics of Drugs)
  • Article
  • Open Access
891 Views
25 Pages

Bioequivalence Evaluation of Immediate-Release Empagliflozin/Metformin Fixed-Dose Combination Tablets Under Fed Conditions in Healthy Mexican Subjects and Exploratory Analysis of Metformin Dose Proportionality

  • Erika Gabriela Guido Ávila,
  • Alberto Martínez Muñoz,
  • Porfirio de la Cruz Cruz,
  • Omar Emmanuel Hernández Piña and ,
  • José Trinidad Pérez-Urizar and
  • Abraham Escobedo-Moratilla
  • + 1 author+ 0 author

31 July 2026

Background/Objectives: Fixed-dose combinations (FDCs) improve therapeutic adherence in type 2 diabetes. These studies aimed to evaluate the pharmacokinetics and establish the bioequivalence of four immediate-release empagliflozin/metformin FDC formul...

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
554 Views
18 Pages

Disulfiram’s Anti-Inflammatory and Antibacterial Effects in Fixed-Dose Combination Therapy for Scabies

  • Carmen Salavastru,
  • Angela Hernández-Martín,
  • Sanja Bulut,
  • Laura Fernàndez Fajardo and ,
  • Aymée Robainas Barcia and
  • Maria Lajarin-Reinares
  • + 1 author+ 0 author

Background/Objectives: Scabies is a highly contagious parasitic skin infestation in which mite infestation, epidermal barrier disruption, secondary bacterial infection, and local inflammation collectively contribute to disease burden. This study inve...

(This article belongs to the Section Drug Targeting and Design)

of 17